scholarly journals Platelets, thrombo-inflammation and cancer

Author(s):  
E. V. Slukhanchuk ◽  
V. O. Bitsadze ◽  
J. Kh. Khizroeva ◽  
M. V. Tretyakova ◽  
A. G. Solopova ◽  
...  

It has long been recognized a crucial role played by platelets in thrombosis and hemostasis. Along with that, laboratory and clinical data suggest that platelets contribute to tumor progression and metastasis through a variety of interactions with cancer cells. During oncological process, the platelet function becomes modulated via their activation and increased aggregation being one of the risk factors for developing thrombosis in cancer patients. The platelets per se enhance tumor cell dissemination, activate endothelial cells, and attract immune cells to the primary and metastatic tumor sites. In this review, we summarize the current knowledge about the complex interactions between platelets and tumor cells, as well as cells of the microenvironment, and discuss the development of new antitumor agents aimed at various arms in platelet functioning.

2021 ◽  
Vol 11 ◽  
Author(s):  
Attila Braun ◽  
Hans-Joachim Anders ◽  
Thomas Gudermann ◽  
Elmina Mammadova-Bach

Although platelets are critically involved in thrombosis and hemostasis, experimental and clinical evidence indicate that platelets promote tumor progression and metastasis through a wide range of physical and functional interactions between platelets and cancer cells. Thrombotic and thromboembolic events are frequent complications in patients with solid tumors. Hence, cancer modulates platelet function by directly inducing platelet-tumor aggregates and triggering platelet granule release and altering platelet turnover. Also, platelets enhance tumor cell dissemination by activating endothelial cell function and recruiting immune cells to primary and metastatic tumor sites. In this review, we summarize current knowledge on the complex interactions between platelets and tumor cells and the host microenvironment. We also critically discuss the potential of anti-platelet agents for cancer prevention and treatment.


Science ◽  
2018 ◽  
Vol 359 (6382) ◽  
pp. 1408-1411 ◽  
Author(s):  
M. Brown ◽  
F. P. Assen ◽  
A. Leithner ◽  
J. Abe ◽  
H. Schachner ◽  
...  

2018 ◽  
Vol 11 (3) ◽  
pp. 289-299 ◽  
Author(s):  
Mayuri Gogoi ◽  
Meghanashree M. Shreenivas ◽  
Dipshikha Chakravortty

Salmonella is a major cause of morbidity and mortality in the developing and underdeveloped nations. Being a foodborne disease, Salmonella infection is primarily contracted through the ingestion of contaminated food or water, or due to close contact with infected/carrier individuals. It is an intracellular pathogen, which can survive and replicate in various cells including macrophages, dendritic cells, epithelial cells, and other white blood cells. Once Salmonella crosses the intestinal barrier, it disseminates to various systemic sites by circulation via immune cells. One of the major cell types which are involved in Salmonella infection are host macrophages. They are the niche for intracellular survival and proliferation of Salmonella and a mode of dissemination to distal systemic sites. These cells are very crucial as they mediate the mounting of an appropriate innate and adaptive anti-Salmonella immune response. In this review, we have tried to concise the current knowledge of complex interactions that occur between Salmonella and macrophages.


Pharmaceutics ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 163
Author(s):  
Kyosuke Yakabe ◽  
Jun Uchiyama ◽  
Masahiro Akiyama ◽  
Yun-Gi Kim

Vaccinations improve the mortality and morbidity rates associated with several infections through the generation of antigen-specific immune responses. Adjuvants are often used together with vaccines to improve immunogenicity. However, the immune responses induced by most on-going vaccines and adjuvants approved for human use vary in individuals; this is a limitation that must be overcome to improve vaccine efficacy. Several reports have indicated that the symbiotic bacteria, particularly the gut microbiota, impact vaccine-mediated antigen-specific immune responses and promote the induction of nonspecific responses via the “training” of innate immune cells. Therefore, the interaction between gut microbiota and innate immune cells should be considered to ensure the optimal immunogenicity of vaccines and adjuvants. In this review, we first introduce the current knowledge on the immunological mechanisms of vaccines and adjuvants. Subsequently, we discuss how the gut microbiota influences immunity and highlight the relationship between gut microbes and trained innate immunity, vaccines, and adjuvants. Understanding these complex interactions will provide insights into novel vaccine approaches centered on the gut microbiota.


2010 ◽  
Vol 8 (10) ◽  
pp. 1297-1309 ◽  
Author(s):  
Mélanie Héroult ◽  
Florence Schaffner ◽  
Dennis Pfaff ◽  
Claudia Prahst ◽  
Robert Kirmse ◽  
...  

2020 ◽  
Vol 42 (5) ◽  
pp. 559-572 ◽  
Author(s):  
Weili Xu ◽  
Glenn Wong ◽  
You Yi Hwang ◽  
Anis Larbi

AbstractFrom a holistic point of view, aging results from the cumulative erosion of the various systems. Among these, the immune system is interconnected to the rest as immune cells are present in all organs and recirculate through bloodstream. Immunosenescence is the term used to define the remodelling of immune changes during aging. Because immune cells—and particularly lymphocytes—can further differentiate after their maturation in response to pathogen recognition, it is therefore unclear when senescence is induced in these cells. Additionally, it is also unclear which signals triggers senescence in immune cells (i) aging per se, (ii) specific response to pathogens, (iii) underlying conditions, or (iv) inflammaging. In this review, we will cover the current knowledge and concepts linked to immunosenescence and we focus this review on lymphocytes and T cells, which represent the typical model for replicative senescence. With the evidence presented, we propose to disentangle the senescence of immune cells from chronological aging.


2006 ◽  
Vol 12 (9) ◽  
pp. 2894-2901 ◽  
Author(s):  
Jillian R. Brown ◽  
Mark M. Fuster ◽  
Ruixia Li ◽  
Nissi Varki ◽  
Charles A. Glass ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document